By using this site, you agree to the Privacy Policy and Terms of Use. We improve our products and advertising by using Microsoft Clarity to see how you use our website. By using our site, you agree that we and Microsoft can collect and use this data. Our privacy statement has more details Privacy Policy
Accept
GOGO MagazineGOGO Magazine
  • Home
  • Categories
    • Art
    • BlogNew
    • Featuring
    • Health
      • Food
    • Lifestyle
    • Music
    • Photography
    • Politics
    • Reviews
      • Cafe Reviews
    • Social
    • Sports
    • Tech
    • Travel
    • Travel Stories
  • My Bookmarks
  • Shop
  • Contact
  • My Account
Search
  • Customize Interests
  • Cart
  • Checkout
Reading: Game Changer Drugs For COVID-19
Share
0

No products in the cart.

Notification Show More
Aa
GOGO MagazineGOGO Magazine
0
Aa
  • Blog
  • Art
  • Travel
  • Social
  • Lifestyle
  • Tech
Search
  • Home
  • Categories
    • Blog
    • Art
    • Travel
    • Social
    • Lifestyle
    • Tech
    • Music
    • Sports
    • Featuring
    • Photography
    • Politics
    • Health
    • Reviews
    • Travel Stories
  • My Bookmarks
  • Shop
  • Contact
  • My Account
Have an existing account? Sign In
Follow US
GOGO Magazine > Blog > Social > Game Changer Drugs For COVID-19
Social

Game Changer Drugs For COVID-19

Saumya Sharma
Last updated: 2020/06/28 at 10:48 PM
Saumya Sharma Published June 28, 2020
Share
4 Min Read
SHARE

COVID-19 is an infectious disease caused by a newly discovered Corona Virus. It is a type of RNA virus that causes infection in the respiratory tract. According to a Chinese study, the virus has developed 2 types of strains until now.

Contents
SIGNS AND SYMPTOMSTREATMENT

SIGNS AND SYMPTOMS

•fever
•dry cough
•fatigue
•body ache
•sore throat
•diarrhoea
•conjuctivitis
•headache
•loss of taste or smell
•rashes

The virus can lead to pneumonia respiratory failure, septic shock, and death. 

TREATMENT

The treatment protocols for coronavirus are being revised from time to time based on emerging evidences. As COVID-19 is a new and emerging disease, there is no specific treatment or vaccine available for it. The patients are being treated by drugs that were already available for various other ailments.
At least five medicines have either been given a go-ahead from the government to treat coronavirus infected patients in India or are in the final stages of the trial being carried out. India has also been using hydroxychloroquine (HCQ), an antimalarial drug, for treating COVID patients. Two Indian firms, Ipca Laboratories and Zydus Cadila Ltd, are the world’s largest manufacturers of the drug.


Another drug that is being used to treat the disease is Remdesivir sold under the brand name Covifor by Hetero in India. It has been granted approval by the Drug Controller General of India( DGCI) for the treatment of suspected or laboratory-confirmed cases of Covid-19 in adults and children, hospitalized with severe symptoms of the disease. Covifor (Remdesivir) will be available in 100 mg vial (injectable) which has to be administered intravenously in a hospital setting under the supervision of a healthcare practitioner. Cipla has also launched its own remedesivir under the name of Cipremi. The drug is most effective for those who need oxygen support.

Glenmark Pharmaceuticals, a research-led pharmaceutical company, received the approval for manufacturing and marketing Favipiravir, an antiviral drug to be used for the treatment of mild to moderate COVID-19 patients, from the DCGI on Friday, 19 June 2020. After this approval, Favipiravir has become the first approved oral medication for the treatment of COVID-19 in India. The drug will be available by the name Fabi flu and is priced at Rs 103 per tablet. The drug should only be taken after medical consultation.

Here are some things you should know about the first approved oral COVID-19 drug in India-
• It is a generic version of Avigan, a Japanese medicine which is basically an anti-influenza drug.
• The recommended dose is 1800 mg twice daily on the first day of medication, followed by 800 mg twice daily up to day 14.
• There isn’t enough data to talk about the efficacy of the drug yet, but Dr. Rommel Tickoo, Associate Director, Internal Medicine, Max Healthcare, said the drug could be a “potential game-changer”, as it can be given in tablet form and is easy to administer and also relatively inexpensive.
• It can be given to patients with co-morbid conditions like diabetes and heart disorders with mild to moderate symptoms of COVID-19.
• Reports show a rapid reduction in viral load within four days and provide faster symptomatic relief.
• Favipiravir offers broad-spectrum RNA virus treatment with improvement noted in a wide range of age groups.

Indian doctors have also been successfully using Methylprednisolone in handling moderate to severe cases of the disease. It reduces its overall mortality and is a more essential part of the treatment regimen. It works by reducing the severity of the symptoms.

Checkout more such content at: https://gogomagazine.in/category/social/

You Might Also Like

HEATWAVES AND POWER CUTS

INDIA SLIPS 8 POSITIONS IN WORLD PRESS FREEDOM INDEX 2022

First human case of H3N8 bird flu

UNCCD Conference of Parties (COP15)

TARA AIR PLANE CRASH – NO SURVIVORS

TAGGED: covid, covid-19, covidfree, doctor, doctors, drug, drugs, fabinflu, favipiravir, glenmark, medical, medication, medicine, medicines, pharmaceuticals, signs, symptoms, virus
Saumya Sharma June 28, 2020 June 28, 2020
Share This Article
Facebook Twitter Whatsapp Whatsapp Reddit Email Copy Link Print
Share
By Saumya Sharma
Follow:
Hi, I am a 22 year old med student pursuing my MBBS from Himachal. Writing is something that I have always loved and to be honest I am a jack of many trades. I like writing and reading fiction more than anything. Other than that non fiction, documentaries, movies, music are the things that I am into. I believe that if I can feel it, I'll be able to write it.
2 Comments 2 Comments
  • Anonymous says:
    June 28, 2020 at 11:02 pm

    4

    Reply
  • Anonymous says:
    August 23, 2020 at 8:31 pm

    1

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Stay Connected

1.5k Followers Like
17.2k Followers Follow
528 Subscribers Subscribe
- Advertisement -
Ad imageAd image

Latest News

JODHPUR – @nancysharma24
Travel July 30, 2023
Athens – @indrafeb
Travel July 1, 2023
Italy – @suhedaydogan
Travel July 1, 2023
ALLEPPEY – @the_enigmatic_escapist
Travel July 1, 2023
TOKYO – @andreabigsac
Travel July 1, 2023
SINGAPORE – @onthegowithnushey
Travel July 1, 2023

You Might Also Like

Social

HEATWAVES AND POWER CUTS

May 30, 2022
Social

INDIA SLIPS 8 POSITIONS IN WORLD PRESS FREEDOM INDEX 2022

May 30, 2022
Social

First human case of H3N8 bird flu

May 30, 2022
Social

UNCCD Conference of Parties (COP15)

May 30, 2022

GOGO Magazine – Keep Rollin Happiness!
Featuring talent and businesses from across the 🌎

Quick Link

  • Shop
  • Contact
  • Customize Interests

Top Categories

  • Blog
  • Art
  • Travel

My Account

  • My Account
  • Cart
  • My Bookmarks

DMCA Protection

DMCA.com Protection Status

Site Report

GOGO MagazineGOGO Magazine
Follow US
© 2022 GOGO Magazine. All Rights Reserved.
Join Us!

Subscribe to our newsletter and never miss our latest news, podcasts etc..

Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Register Lost your password?